Abstract
Extracts obtained from rat hepatocytes incubated with saline, glucagon or insulin were electrophoresed on polyacrylamide gels and then assayed for cyclic (3H)AMP binding capacity. Analysis of the binding patterns demonstrated that glucagon dissociated a holoenzyme of cyclic AMP-dependent protein kinase in a dose-dependent manner. The increase in free regulatory subunits and, hence, in free catalytic subunits explains the activation of this enzyme by glucagon in the liver. Insulin decreased both the amount of cyclic (3H)AMP bound to the holoenzyme and the capacity of the enzyme to be dissociated when the extracts were incubated with increasing concentrations of this cyclic nucleotide. We propose that these insulin-induced effects are determined by an inhibition of the cyclic AMP binding capacity of this protein kinase. This mechanism could account for the inactivation of cyclic AMP-dependent protein kinase that insulin causes in the liver.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- cAMP:
-
(cyclic AMP), Adenosine 3′,5′ monophosphate
- (3H)cAMP:
-
cyclic (3H)AMP
- MIX:
-
1-methyl-3-isobutylxanthine
References
Soderling TR, Hickenbottom JP, Reimann EM, Hunkeler FL, Walsh DA, Krebs EG: Inactivation of glycogen synthetase and activation of phosphorylase kinase by muscle adenosine 3′,5′-monophosphate-dependent protein kinase. J Biol Chem 245:6317–6328, 1970.
Schlender KK, Wei SH, Villar-Palasi C: UDP-glucose: glycogen alpha-4-glucosyltransferase I kinase activity of purified muscle protein kinase. Cyclic nucleotide specificity. Biochim Biophys Acta 191:272–278, 1969.
Hems DA, Whitton PD: Control of hepatic glycogenolysis. In: Schultz SG (ed) Physiological Reviews, Vol 60. The American Physiological Society, Bethesda, Maryland, 1980, pp 1–50.
Mor MA, Vila J, Ciudad CJ, Guinovart JJ: Insulin inactivation of rat hepatocyte cyclic AMP-dependent protein kinase. FEBS Lett 136:131–134, 1981.
Miller TB, Larner J: Mechanism of control of hepatic glycogenesis. J Biol Chem 248:3483–3488, 1973.
Guinovart JJ, Lawrence JC, Larner J: Hormonal effects on fat cell adenosine 3′,5′-monophosphate-dependent protein kinase. Biochim Biophys Acta 539:181–194, 1978.
Walkenbach RJ, Hazen R, Larner J: Reversible inhibition of cyclic AMP-dependent protein kinase by insulin. Mol Cell Biochem 19:31–41, 1978.
Guinovart JJ, Larner J: Epinephrine effects on cyclic AMP-dependent protein kinases from rat diaphragms. Biochim Biophys Acta 631:253–263, 1980.
Walkenbach RJ, Hazen R, Larner J: Hormonal regulation of glycogen synthase. Insulin decreases protein kinase sensitivity to cyclic AMP. Biochim Biophys Acta 629:421–430, 1980.
Massagué J, Guinovart JJ: Insulin counteraction of alphaadrenergic effects on liver glycogen metabolism. Biochim Biophys Acta 543:269–272, 1978.
Davis BJ: Disc electrophoresis-11. Method and application to human serum protein. Ann NY Acad Sci 121:404–427, 1964.
Hirsh A, Rosen DM: An assay for protein kinase activity on polyacrylamide gels. Anal Biochem 60:389–394, 1974.
House PDR, Poulis P, Werdemann MJ: Isolation of a plasma membrane subfraction from rat liver containing an insulin sensitive cyclic AMP phosphodiesterase. Eur J Biochem 24:429–437, 1972.
Larner J, Galasko G, Cheng K, De Paoli-Roach AA, Huang L, Daggy P, Kellog J: Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation. Science 206:1408–1410, 1979.
Ciudad CJ, Bosch F, Ginovart JJ: Insulin activation of basal hepatic glycogen synthase. FEBS Lett 129:123–126, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ciudad, C.J., Vila, J., Mor, M. et al. Effects of glucagon and insulin on the cyclic AMP binding capacity of hepatocyte cyclic AMP-dependent protein kinase. Mol Cell Biochem 73, 37–44 (1987). https://doi.org/10.1007/BF00229374
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00229374